This includes the potential of medical cannabis as a treatment for arthritis symptoms and the importance of seeking guidance from health care practitioners. The Arthritis Society is a leading charitable funder of arthritis research whose vision is to live in a world where people are free from the devastating effects of arthritis.
The partnership will engage Canadians across the country in a series of symposiums titled “Arthritis Talks,” presented by the Arthritis Society and Spectrum Cannabis. The series consists of a comprehensive program of in-person and digitally-accessible education events across Canada featuring leading speakers on topics that are of high interest and relevance to people living with arthritis.
Spectrum Cannabis and the Arthritis Society are also committed to creating a range of evidence-based resources that will enable people with arthritis to make informed decisions regarding medical cannabis. These resources which will be developed over the coming months and available on Arthritis.ca, range from infographics to educational videos and an online guide that will feature content backed by the latest evidence available to guide patients through the process of making decisions about medical cannabis.
Today, one in five people across Canada live with arthritis; that’s about six million Canadians and the prevalence of arthritis is on the rise.
It’s estimated that as many as one in four Canadians will have arthritis by 2040, a projected 50% increase.
“Many people today have significant unmet medical needs, particularly with conditions such as arthritis where standard therapies have produced sub-par results,” commented Dr. Mark Ware, Chief Medical Officer, Canopy Growth. “Our partnership with the Arthritis Society aligns with our commitment to set the industry standard for awareness and education surrounding medical cannabis and its various therapeutic benefits including its potential as a treatment for those living with arthritis.”
“For people with arthritis, symptoms like chronic pain and fatigue can seriously erode your quality of life,” says Arthritis Society Chief Science Officer, Dr. Siân Bevan. “While medical cannabis may offer the possibility of some relief, these patients and their physicians need credible, evidence-based guidance with which to make informed treatment decisions. The Arthritis Society continues to lead the way in calling for and funding innovative research and education initiatives to address this urgent need, and we are pleased to partner with Spectrum Cannabis to empower Canadians living with arthritis to make the treatment decisions that are right for them.”
Arthritis Talks: Nourish & Flourish, the first event of this exciting series takes place on Saturday, May 4, 2019 in both Calgary and Winnipeg. Experts in nutrition, physical activity and medical cannabis will bring current research and information about arthritis to in-person attendees and online participants through a live, interactive webcast. Event information and registration instructions can be found on the Arthritis Society website.
Spectrum Cannabis: Medical Cannabis. Simplified.
About the Arthritis Society
The Arthritis Society is a national health charity, fueled by donors and volunteers, with a vision to live in a world where people are free from the devastating effects that arthritis has on lives. Begun in 1948 with one very clear goal – to alleviate the suffering of people crippled by arthritis – that same volunteer-led passion carries on today in communities across Canada. Through the trust and support of our donors and sponsors, the Arthritis Society is Canada’s largest charitable source of investments in cutting-edge arthritis research, proactive advocacy and innovative solutions that will deliver better health outcomes for people affected by arthritis. The Arthritis Society is accredited under Imagine Canada’s Standards Program. For more information and to make a donation, visit arthritis.ca.
About Spectrum Cannabis
Spectrum Cannabis, a wholly-owned subsidiary of Canopy Growth, is dedicated to simplifying medical cannabis for patients and healthcare practitioners worldwide. Founded in Canada, Spectrum Cannabis operates in Australia, South America, Africa and across Europe. Spectrum Cannabis products are available in a wide range of potencies and formats designed to simplify the dialogue around strength and dosage by applying a colour-coded Spectrum to categorize medical cannabis according to THC and CBD levels. Its product lineup includes whole flower cannabis, oils and new innovations such as Softgels. Through product simplification, easy dosing formats, and ongoing education of healthcare professionals, Spectrum Cannabis is committed to improving the lives of medical cannabis patients around the globe.
About Canopy Growth
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Canopy Growth offers medically approved vaporizers through the Company’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.